An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry

Xavier G. L. Pouwels, Bram L. T. Ramaekers*, Sandra M. E. Geurts, Frans Erdkamp, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Agnes J. van de Wouw, M. W. Dercksen, Tineke J. Smilde, Natascha A. J. B. Peters, J. M. G. H. van Riel, Manon J. Pepels, Jose Heijnen-Mommers, Vivianne C. G. Tjan-Heijnen, Maaike de Boer, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1123-1130
Number of pages8
JournalActa Oncologica
Volume59
Issue number9
DOIs
Publication statusPublished - 16 Jun 2020

Keywords

  • COST-EFFECTIVENESS
  • PRICE

Cite this